P3 Health Partners (PIII) Capital Expenditures (2021 - 2025)

P3 Health Partners has reported Capital Expenditures for 4 years, with the latest figure at -$198000.0 in Q4 2025.

• For the quarter ending Q4 2025, Capital Expenditures changed N/A year-over-year to -$198000.0; the trailing twelve-month figure through Dec 2025 stood at -$198000.0 (changed N/A YoY), and the FY2025 full-year result was -$79000.0, changed N/A from the prior year.
• Capital Expenditures for Q4 2025 stood at -$198000.0, up from -$212000.0 in the prior quarter.
• The five-year high for Capital Expenditures was $1.2 million in Q2 2021, with the low at -$212000.0 in Q4 2023.
• Historically, Capital Expenditures has averaged $571010.8 across 4 years, with a median of $590088.5 in 2021.
• The largest YoY upside for Capital Expenditures was 126.72% in 2023 against a maximum downside of 324.0% in 2023.
• P3 Health Partners' Capital Expenditures stood at $1.1 million in 2021, then slumped by 104.52% to -$50000.0 in 2022, then tumbled by 324.0% to -$212000.0 in 2023, then advanced by 6.6% to -$198000.0 in 2025.
• The last three Capital Expenditures figures came in at -$198000.0 (Q4 2025), -$212000.0 (Q4 2023), and $387000.0 (Q3 2023), per Business Quant data.